30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ashish Mandelia

Insider profile

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Vice President, Controller Mersana Therapeutics Inc July 1, 2019 - Dec. 31, 2019

Ashish Mandelia's trades of Mersana Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-17 2025-01-16 PlS Planned sale
13,095 +14.4%
246.63
US$553,374
13,095 +14.4% 246.63 US$553,374
2025-01-16 2025-01-15 PlS Planned sale
25,753 -49.3%
469.97
US$4,579,521
25,753 -49.3% 469.97 US$4,579,521
2025-01-15 2025-01-14 PlS Planned sale
13,269 +46.4%
100.71
US$1,594,013
13,269 +46.4% 100.71 US$1,594,013
2024-10-07 2024-10-03 PlS Planned sale
3,361 -6.6%
1.96
US$6,588
3,361 -6.6% 1.96 US$6,588
2024-10-07 2024-10-02 PlS Planned sale
4,855 -8.7%
2.00
US$9,710
4,855 -8.7% 2.00 US$9,710
2024-01-17 2024-01-16 PlS Planned sale
5,025 -17.7%
2.71
US$13,618
5,025 -17.7% 2.71 US$13,618
2023-01-18 2023-01-17 S Sale
3,575 -20.8%
5.74
US$20,520
3,575 -20.8% 5.74 US$20,520
2022-01-19 2022-01-18 S Sale
1,982 -37.0%
5.92
US$11,733
1,982 -37.0% 5.92 US$11,733
2021-01-20 2021-01-19 PlS Planned sale
545 -100.0%
21.28
US$11,598
545 -100.0% 21.28 US$11,598
2021-01-06 2021-01-04 PlS Planned sale
247 -100.0%
26.76
US$6,610
247 -100.0% 26.76 US$6,610
2020-07-06 2020-07-02 PlS Planned sale
3,383 -100.0%
22.49
US$76,084
3,383 -100.0% 22.49 US$76,084
2020-07-06 2020-06-30 B Purchase
3,383 +inf%
4.87
US$16,475
3,383 +inf% 4.87 US$16,475